MXCT vs TM
MaxCyte Inc (MXCT) versus Toyota Motor Corporation ADR (TM) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
MXCT currently screens at market cap $124.3M. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Not investment advice. Open the MXCT and TM stock pages for the full models.
Not investment advice.